UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

HDL and cardiovascular disease

The Lancet (British edition), 2014-08, Vol.384 (9943), p.618-625

2014

Link zum Volltext

Verfügbarkeit prüfen

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

The Lancet (British edition), 2021-05, Vol.397 (10289), p.2060-2069

2021

Link zum Volltext

Verfügbarkeit prüfen

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-01, Vol.385 (9965), p.331-340

2015

Link zum Volltext

Verfügbarkeit prüfen

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

Circulation (New York, N.Y.), 2018-08, Vol.138 (8), p.770-781

2018

Link zum Volltext

Verfügbarkeit prüfen

Evinacumab for Homozygous Familial Hypercholesterolemia

The New England journal of medicine, 2020-08, Vol.383 (8), p.711-720

2020

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting PCSK9 - biology beyond LDL control

Nature reviews. Endocrinology, 2019-01, Vol.15 (1), p.52-62

2019

Link zum Volltext

Verfügbarkeit prüfen

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

European heart journal, 2015-11, Vol.36 (43), p.2996-3003

2015

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

The New England journal of medicine, 2023-09, Vol.389 (12), p.1069-1084

2023

Link zum Volltext

Verfügbarkeit prüfen

The PCSK9 decade

Journal of lipid research, 2012-12, Vol.53 (12), p.2515-2524

2012

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-01, Vol.385 (9965), p.341-350

2015

Link zum Volltext

Verfügbarkeit prüfen

NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

Trends in endocrinology and metabolism, 2019-12, Vol.30 (12), p.891-902

2019

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

The American heart journal, 2020-11, Vol.229, p.61-69

2020

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

The New England journal of medicine, 2023-12, Vol.389 (24), p.2221-2232

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen

The journal of clinical endocrinology and metabolism, 2019-06, Vol.104 (6), p.1937-1947

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus

JAMA : the journal of the American Medical Association, 2015-03, Vol.313 (10), p.1029

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel

Journal of the American College of Cardiology, 2018-08, Vol.72 (6), p.662-680

2018

Link zum Volltext

Verfügbarkeit prüfen

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials

Journal of lipid research, 2022-01, Vol.63 (1), p.100148-100148, Article 100148

2022

Link zum Volltext

Verfügbarkeit prüfen

ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia

The New England journal of medicine, 2017-07, Vol.377 (3), p.296-297

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

BMC medicine, 2015-09, Vol.13 (1), p.229-229, Article 229

2015

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and treatment of familial hypercholesterolaemia

European heart journal, 2013-04, Vol.34 (13), p.962-971

2013

Link zum Volltext

Verfügbarkeit prüfen

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome

European heart journal, 2015-03, Vol.36 (9), p.560-565

2015

Link zum Volltext

Verfügbarkeit prüfen

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

The New England journal of medicine, 2020-10, Vol.383 (14), p.1317-1327

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials

Thrombosis and haemostasis, 2016-03, Vol.115 (3), p.520

2016

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

The Lancet (British edition), 2015-08, Vol.386 (9992), p.452-460

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(284)

Publikationsform

Artikel
(312)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(227)
Humans
(200)
Cardiovascular System & Cardiology
(133)
Male
(118)
Female
(115)
Cardiac & Cardiovascular Systems
(111)
Middle Aged
(96)
Adult
(72)
Cholesterol
(63)
Peripheral Vascular Disease
(61)
Risk Factors
(61)
Aged
(58)
Cardiovascular Disease
(56)
Mutation
(51)
Cardiovascular
(45)
Hyperlipoproteinemia Type Ii - Genetics
(44)
Cholesterol, Ldl - Blood
(43)
Atherosclerosis
(40)
Familial Hypercholesterolemia
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

HDL and cardiovascular disease

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

Evinacumab for Homozygous Familial Hypercholesterolemia

Inhibiting PCSK9 - biology beyond LDL control

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

The PCSK9 decade

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen

Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials

ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

Diagnosis and treatment of familial hypercholesterolaemia

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

Suchergebnisse filtern